Header cover image

German (DAX) Pharma Industry Analysis

UpdatedMar 24, 2026
DataAggregated Company Financials
Companies9
  • 7D-5.0%
  • 3M-5.6%
  • 1Y4.7%
  • YTD-8.0%

Over the last 7 days, the Pharma industry has dropped 3.9%, driven by a pullback from Merck KGaA of 5.1%. In the past year, the industry has gained 5.5%. As for the next few years, earnings are expected to grow by 29% per annum.

Industry Valuation and Performance

Has the German Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 24 Mar 2026€85.3b€67.9b-€900,280,549.2618.2x-94.8x1.3x
Thu, 19 Feb 2026€103.5b€68.3b€2.9b18.3x36.1x1.5x
Sat, 17 Jan 2026€100.1b€68.3b€2.9b18.2x34.9x1.5x
Mon, 15 Dec 2025€89.8b€68.3b€2.9b17.3x31.4x1.3x
Wed, 12 Nov 2025€79.0b€68.8b-€439,217,305.7818.2x-179.8x1.1x
Fri, 10 Oct 2025€82.1b€68.8b-€438,983,431.1819x-187x1.2x
Sun, 07 Sep 2025€78.4b€68.9b-€406,177,264.3117.1x-192.9x1.1x
Tue, 05 Aug 2025€77.2b€69.4b-€289,971,681.4717.2x-266.2x1.1x
Thu, 03 Jul 2025€77.4b€69.4b-€283,071,598.0017.8x-273.4x1.1x
Sat, 31 May 2025€77.0b€69.4b-€209,654,848.0018x-367.5x1.1x
Mon, 28 Apr 2025€77.9b€69.3b€463.1m18.6x168.2x1.1x
Wed, 26 Mar 2025€82.7b€69.2b€436.0m20.5x189.8x1.2x
Fri, 21 Feb 2025€83.3b€69.2b€2.0b22x41.1x1.2x
Sun, 19 Jan 2025€85.0b€69.2b€2.0b22.8x42.3x1.2x
Tue, 17 Dec 2024€82.9b€69.2b€2.0b22.3x40.9x1.2x
Thu, 14 Nov 2024€87.9b€69.1b€1.9b20.3x45.2x1.3x
Sat, 12 Oct 2024€96.3b€69.4b€1.6b20.7x61.7x1.4x
Mon, 09 Sep 2024€104.0b€69.3b€1.5b24.5x70.6x1.5x
Wed, 07 Aug 2024€97.9b€69.2b-€399,627,757.0030x-245x1.4x
Fri, 05 Jul 2024€94.6b€69.2b-€303,627,757.0029.4x-311.7x1.4x
Sun, 02 Jun 2024€102.7b€69.2b-€308,637,180.0020.7x-332.9x1.5x
Tue, 30 Apr 2024€94.6b€70.0b-€34,208,180.0020.9x-2765.4x1.4x
Thu, 28 Mar 2024€100.0b€70.0b€6.5m18.4x15394.1x1.4x
Sat, 24 Feb 2024€100.1b€70.6b-€650,504,143.0019.2x-153.9x1.4x
Mon, 22 Jan 2024€98.0b€70.6b-€650,504,143.0020.4x-150.7x1.4x
Wed, 20 Dec 2023€96.3b€70.6b-€650,606,256.0019.3x-148.1x1.4x
Fri, 17 Nov 2023€110.4b€70.6b-€625,796,256.0016.9x-176.4x1.6x
Sun, 15 Oct 2023€110.8b€72.1b€4.7b19x23.7x1.5x
Tue, 12 Sep 2023€125.0b€72.1b€4.7b21.6x26.9x1.7x
Thu, 10 Aug 2023€124.6b€73.9b€6.3b18.3x19.8x1.7x
Sat, 08 Jul 2023€114.6b€74.1b€6.5b17.9x17.8x1.5x
Mon, 05 Jun 2023€127.5b€74.1b€6.4b22.4x19.9x1.7x
Wed, 03 May 2023€128.5b€74.2b€7.6b20.8x17x1.7x
Fri, 31 Mar 2023€134.1b€74.2b€7.6b18.8x17.6x1.8x
Price to Earnings Ratio

17.6x


Total Market Cap: €134.1bTotal Earnings: €7.6bTotal Revenue: €74.2bTotal Market Cap vs Earnings and Revenue0%0%0%
German Pharma Industry Price to Earnings3Y Average 130.1x202420252026
Current Industry PE
  • Investors are relatively neutral on the German Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 1.4x.
Past Earnings Growth
  • Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 2.9% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market-3.34%
Healthcare-4.44%
Pharma-5.00%
Pharma-5.00%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DMP Dermapharm Holding€41.350.9%
+€18.8m
2.0%PE19.2x

Latest News